An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Physicians Realty Trust (NYSE:DOC) declared a quarterly cash dividend of $0.23 per share for the quarter ending December 31, 2022. This marks the 38th consecutive quarterly dividend. The dividend will be paid on January 18, 2023, to shareholders of record on January 4, 2023. The company is set to release its fourth-quarter financial results before the market opens on February 22, 2023, with a conference call scheduled for the same day at 10:00 a.m. ET.
Positive
Declared a quarterly cash dividend of $0.23, signaling financial stability.
MILWAUKEE--(BUSINESS WIRE)--
Physicians Realty Trust (NYSE:DOC) (the “Company”) announced today that the Company’s Board of Trustees has authorized, and the Company has declared, a quarterly cash dividend of $0.23 per common share and unit for the quarter ending December 31, 2022. “We are proud to declare and pay our 38th consecutive quarterly dividend. This year has been a strong year focused on maintaining and improving our existing portfolio while delivering reliable cash flows during recent market uncertainty. We are looking forward to sharing more about our fourth quarter 2022 results in our earnings release and related conference call, scheduled for February 22, 2023,” said John T. Thomas, the Company’s President and Chief Executive Officer.
The dividend will be payable on January 18, 2023, to common shareholders and unit holders of record on January 4, 2023.
Earnings Release and Conference Call Information
The Company announced it will release its financial results for the fourth quarter ended December 31, 2022, before the market opens on February 22, 2023, and will hold a conference call on this day at 10:00 a.m. ET to discuss the financial results and provide a company update. The conference call will be hosted by President and Chief Executive Officer John Thomas, Executive VP and Chief Financial Officer Jeff Theiler, Executive VP of Asset Management Mark Theine, and Chief Accounting and Administrative Officer John Lucey.
The conference call can be accessed by dialing (877) 407-0784 from within the U.S. or (201) 689-8560 for international callers. Participants can reference the Physicians Realty Trust Fourth Quarter Earnings Call or passcode 13735126. The conference call also will be available via a live listen-only webcast and can be accessed through the Investor Relations section of the Company’s website, www.docreit.com. A replay of the conference call will be available beginning February 22, 2023, at 2:00 p.m. ET until March 22, 2023 at 11:59 p.m. ET, by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (International); passcode: 13735126. A replay of the webcast also will be accessible on the Investor Relations website for one year following the event. Beginning February 22, 2023, the Company’s supplemental information package for the fourth quarter 2022 also will be accessible through the Investor Relations section of the Company’s website under the “Supplemental Information” tab.
About Physicians Realty Trust
Physicians Realty Trust is a self-managed health care real estate company organized to acquire, selectively develop, own and manage health care properties that are leased to physicians, hospitals and health care delivery systems. The Company invests in real estate that is integral to providing high quality health care. The Company is a Maryland real estate investment trust and has elected to be taxed as a REIT for U.S. federal income tax purposes. The Company conducts its business through an UPREIT structure in which its properties are owned by the Operating Partnership, directly or through limited partnerships, limited liability companies or other subsidiaries.
Forward-Looking Statements
This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, “continue”, “intend”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward looking statements may include statements regarding the Company’s strategic and operational plans, the Company’s ability to generate internal and external growth, the future outlook, anticipated cash returns, cap rates or yields on properties, anticipated closing of property acquisitions, ability to execute its business plan, and the impact of the COVID-19 pandemic on the Company’s business. While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward looking statements. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual results to differ materially from such statements. These risks and uncertainties are described in greater detail in the Company’s filings with the Securities and Exchange Commission (the “Commission”), including, without limitation, the Company’s annual and periodic reports and other documents filed with the Commission. Unless legally required, the Company disclaims any obligation to update any forward-looking statements after the date of this release, whether as a result of new information, future events or otherwise. For a discussion of factors that could impact the Company’s results, performance, or transactions, see Part I, Item 1A (Risk Factors) of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.
